|
|
41
|
|
|
4181J
|
|
|
ACTEMRA 162MG/0.9ML INJ (ROC) TOCILIZUMA (C)
|
|
|
TOCILIZUMAB
|
|
|
ACTEMRA
|
|
|
4X0.9ML
|
|
|
C
|
|
|
1698.95
|
|
|
424.7381
|
|
|
162MG/0.9ML
|
|
|
AMP
|
|
|
0
|
|
|
BOX
|
|
|
ROC
|
|
|
ROCHE SERVICIOS S.A.
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
N
|
|
|
9236
|
|
|
DISEASE MODIFYING ANTIRHEUMATIC AGENTS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
DISEASE MODIFYING ANTIRHEUMATIC AGENTS
|
|
|
|